ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,926Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 41

$715K Total Retail Price of All Prescriptions

Rank: 5 out of 41

536 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 536 patients filled at least one prescription for a schedule two drug, compared to an average of 11%.

Schedule Three
Controlled Substances

7% of this provider’s 536 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

0% of this provider’s 11,566 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
AMLODIPINE BESYLATE 550 517 1 9
OMEPRAZOLE 523 471 2 2
SIMVASTATIN 519 476 3 3
LISINOPRIL 515 471 4 1
FUROSEMIDE 418 373 5 5
LEVOTHYROXINE SODIUM 376 349 6 4
METOPROLOL SUCCINATE 353 340 7 16
ATORVASTATIN CALCIUM 351 322 8 26
METOPROLOL TARTRATE 331 308 9 7
HYDROCHLOROTHIAZIDE 293 284 10 12
TRAMADOL HCL 234 179 11 18
POTASSIUM CHLORIDE 233 223 12 20
PAROXETINE HCL 223 205 13 39
WARFARIN SODIUM 222 198 14 6
ATENOLOL 219 193 15 10
METFORMIN HCL 209 179 16 19
GABAPENTIN 198 166 17 11
ISOSORBIDE MONONITRATE ER 191 188 18 34
HYDROCODONE-ACETAMINOPHEN 184 167 S3 19 33
TRAZODONE HCL 170 138 20 14
MIRTAZAPINE 165 160 21 15
OXYCODONE-ACETAMINOPHEN 150 148 S2 22 70
PROAIR HFA 137 135 23 74
LOSARTAN POTASSIUM 135 126 24 23
DIGOXIN 132 126 25 38
CLOPIDOGREL 132 129 25 56
PREDNISONE 123 111 27 27
HYDRALAZINE HCL 118 109 28 60
ALENDRONATE SODIUM 115 111 29 29
PLAVIX 105 101 30 69
FLUTICASONE PROPIONATE 105 98 30 50
ADVAIR DISKUS 102 99 32 57
ALLOPURINOL 95 88 33 43
GLIPIZIDE ER 93 93 34 110
TAMSULOSIN HCL 92 86 35 32
SPIRIVA 91 76 36 58
GLIPIZIDE XL 89 71 37 131
CITALOPRAM HBR 87 75 38 8
DIOVAN 86 86 39 82
DONEPEZIL HCL 76 76 40 13
TERAZOSIN HCL 76 76 40 135
LANTUS 71 48 42 25
LANTUS SOLOSTAR 67 62 43 67
DIVALPROEX SODIUM 66 45 44 35
TRIAMTERENE-HCTZ 62 59 45 65
GLIPIZIDE 60 52 46 53
NOVOLOG 60 40 46 42
LEVETIRACETAM 56 52 48 50
CLONIDINE HCL 56 47 48 121
AZITHROMYCIN 55 44 50 87
RANITIDINE HCL 55 43 50 40
CARVEDILOL 53 31 52 41
OXYCODONE HCL 52 40 S2 53 37
LIPITOR 52 44 53 161
ISOSORBIDE DINITRATE 51 51 55 125
OXYCONTIN 50 50 S2 56 84
QUETIAPINE FUMARATE 50 25 56 21
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 19, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.